Eyenovia announces development collaboration agreement with formosa pharmaceuticals

Collaboration will combine eyenovia's optejet® dispensing technology with formosa's apnt™ nanoparticle formulation platform for the potential development of new topical therapeutics in high-value ophthalmic indications with significant unmet medical needs. collaboration will combine eyenovia's optejet® dispensing technology with formosa's apnt™ nanoparticle formulation platform for the potential development of new topical therapeutics in high-value ophthalmic indications with significant unmet medical needs.
EYEN Ratings Summary
EYEN Quant Ranking